- Enzyme induction occurs, for example, in CYP450 enzymes in response to chronic exposure to their substrate
- It leads to increased CYP450 enzyme concentration and can reduce the available concentration of drugs metabolised by the induced enzymes
- Examples include:
| CYP1A2 | CYP2B6/2C9 | CYP2C19 | CYP2E1 | CYP3A4 |
| Omeprazole | Barbiturates | Prednisolone | Ethanol (chronic) | Phenytoin |
| Tobacco | Rifampicin | Rifampicin | Isoniazid | Barbiturates |
| Carbamazepine | Carbamazepine | |||
| Rifampicin | ||||
| Glucocorticoids |
- Specific examples of relevant clinical interactions include:
- Phenytoin and carbamazepine will reduce vecuronium (CYP3A4) duration
- Rifampicin and carbamazepine will reduce warfarin (CYP2C9) efficacy
- Rifampicin will reduce ciclosporin efficacy
- Barbiturates will reduce corticosteroid efficiency